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Evolutionary theory: coping
with a pandemic
Professor Lawrence C Scharmann from the University of Nebraska
talks about why scientists keep changing their minds about COVID19 recommendations and the importance of reliable data
the previous edition of The Innovation
Platform, I delineated how biologists,
infectious disease specialists, and healthcare
professionals make use of the evolutionary principle of
common ancestry as a problem-solving lens. We apply
this lens each time we encounter an infectious disease.
The first question to be asked is whether the disease
is already known. If it is known we can mitigate the
spread of the disease based on existing strategies (e.g.
quarantining, isolation, vaccination). If it is new,
however, the next question posed is: ‘does this new
disease at the very least closely resemble other known
diseases?’ Asking this secondary question and
identifying logical similarities permits the potential
development of a vaccine more quickly than it would
otherwise occur – this happens yearly, for example,
with strains of influenza. When the answer, however, is
that the infectious disease is completely novel and not
sufficiently resembling an already known disease, the
work to create viable vaccines becomes more
daunting, time-consuming, and requires rigorous
protocols of clinical trials in sequential phases.

two simple mitigation techniques were used to
‘flatten the curve’ of infectious transmission and slow
the spread of the disease. Sound familiar?

The Spanish Flu

In a 1948 speech to the British House of Commons,
Winston Churchill, paraphrasing a 1905 maxim
attributed to George Santayana, asserted: “Those who
fail to learn from history are condemned to repeat it.”3

IN

There was a time in history when influenza A was an
unknown, novel virus. We now know it to be an
example of an H1N11 virus of avian origin.2 This
specific novel virus, labelled the Spanish Flu, caused
a pandemic between 1918 and 1919 in which deaths
numbered nearly 50 million worldwide. Lacking a
vaccine, known therapeutics, or other medicines to
effectively treat influenza A, mitigation techniques
consisted of the widespread use of face coverings
(masks, cloth kerchiefs, bandanas) and the practice
of physical distancing when in public spaces. These

The high number of deaths resulting from the
Spanish Flu, it is speculated, might have been
caused by a cytokine storm produced in the body. A
cytokine storm, or hypercytokinemia, is a
physiological immune response in which excessive
quantities of cytokine (a normal part of the human
immune infectious response) overwhelmed and
caused multisystem organ failure. Thankfully, today,
since we now have multiple examples of influenza
viruses, infectious disease specialists can monitor
outbreaks, identify subtypes (e.g. H1N1, H1N2,
H3N1, H2N3), and produce seasonal vaccines with
reasonable certainty that they will provide protection
against severe infection. The yearly effectiveness of
a flu vaccine, nonetheless, varies from year to year,
depending on how closely the new influenza virus
resembles known influenza strains.

COVID-19 (a coronavirus)

Early in 2020, nations across the globe were warned
about the potential for a pandemic arising from a
novel virus that originated in Wuhan, China. The virus
began an inevitable steady march of infection locally,
regionally, nationally, and eventually internationally.
Questions posed earlier in this essay were
appropriately applied:
• Is the infectious disease one that is already
known? Answer: no.
• Does the infectious disease (at the very least)
closely resemble other known diseases? Answer –
other than the virus possessing a distinguishing
corona or halo when viewed under electron
microscopy – no.
Thus, other than identifying the morphological shape
of the virus, it was identified as novel. The official
name, 2019 coronavirus disease, is shortened to a
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designation of type and year of discovery, or COVID19.4
Lacking existing known strategies to cope with the
COVID-19 pandemic, infectious disease specialists
recommended immediate ‘shelter in place’
shutdowns. The purpose of the shutdowns was to
minimise disease spread and (of equal importance)
to gain valuable time to further examine the structure
and characteristics of COVID-19 that could result in
greater specificity concerning those mitigation
strategies that would have the most efficacious
effects in slowing the spread of the disease.

Scientists changing their minds
Initial data obtained from Europe and Asia were
inconclusive regarding how long COVID-19 would
remain viable/virulent:
• As droplets suspended in the air (and at what
distance one would be safe in proximity to other
people)
• On various surfaces (e.g., door handles, light
switches, food packaging, grocery bags)
• Through interpersonal physical transfer/touch.
Without
more
data,
the
specificity
of
recommendations could not be reliably determined.
Early in the pandemic, for example, it was
recommended that we physically distance at six to10
feet, wear a face covering, wipe down our grocery
purchases with a disinfectant, avoid handshakes, not
gather in numbers greater than 100. One year later,
we are not as concerned about touching items at the
grocery store; nor do we feel the need to wipe down
our grocery purchases with a disinfectant. In addition,
the number of individuals gathering indoors changed
to 50 and then 10. Universities and schools spent part
of the spring and all summer of 2020 trying to follow
changing guidelines for safely reopening. Why the
changes in the recommendations? Because we had
learned, through collected data and experiences with
COVID-19, what the most effective tools were for
slowing the spread, flattening the curve, and
mitigating the rate of infection.
It has been determined that COVID-19 is a highly
infectious, airborne virus, that cares nothing about
politics, mental fatigue, or an infringement on
personal liberties. Until viable effective vaccines are
fully distributed and administered to 70% or more of
the world’s population in order to achieve herd
immunity,5 the best tool we have in our arsenal to
mitigate the pandemic remains wearing a simple face
covering when in public spaces, while physically
distancing at a minimum of six feet and keeping large
gatherings to a minimum to avoid unnecessary
‘super-spreading’ events of the COVID-19 virus.
However, because of political differences, economic
concerns, human desires for contact and normalcy,
and even selfish behaviours, the rates of infection
and mortality due to COVID-19 will continue to spike
– again and again – in various geographic regions of
planet Earth until herd immunity can be achieved.

Will there be a need for another shutdown? Do we
need to return to shelter in place policies? Not
necessarily – but we need, collectively as a
population of local, regional, national, and
international citizens, to be on the same page with
one another in order to avoid renewed needs for
shutdowns and shelter in place mandates. Now that
we have more reliable data, we can, with prudence,
reopen with modest normalcy with an eye to the
realities of a virus that has a mind of its own and
cares not one lick about what we want or who we
are. One cannot simply wish COVID-19 away – no
matter how much we might want to do so.
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